Deal Announcement

goetzpartners advised Penta Investment

goetzpartners advised Penta exclusively in the acquisition of Lloyds Pharmacies and a pharmaceutical distributor in the Czech Republic

Sell-Side Advisory
Healthcare and Life Sciences
Transaction
December 2012
Icon: flag-CZIcon: flag-CZ

goetzpartners advised

Penta Investment on the

Acquisition

of Lloyds Pharma

Value not disclosed

Penta Investments, the Central European investment group, has agreed with Celesio AG to acquire its Lloyds pharmacy chain and Gehe wholesale distributor. The purchase price reached EUR 84.5 million. Lloyds operates 55 pharmacies and is the third largest pharmacy chain in the Czech Republic, while Gehe is the fourth biggest wholesale pharmaceutical distributor in the Czech Republic. The transaction is subject to the Czech antitrust authority clearance. Fortlane Partners acted as exclusive financial advisor to Penta in this transaction.

 

The Lloyds pharmacies will be integrated into Ceska lekarna, a.s, which operates the Dr. Max pharmacy chain on the Czech market.

 

"We are consolidating pharmacies in Central Europe through Dr. Max and its local platforms. The Lloyds pharmacies and an important distributor Gehe have therefore been a very reasonable target for us. We strongly believe that market consolidation in the pharmacy sector significantly contributes to better quality and accessibility of services for patients," said Václav Jirků, Investment Director at Penta.

 

"The integration of Lloyds pharmacies will support our efforts to become the most accessible pharmacy chain in terms of price and location, while the Gehe acquisition is an opportunity to implement our successful Dr. Max business model to the wholesale market. We plan to attract Gehe's independent clients with strategies similar to those we used in the retail market, namely competitive price and services," said Pavel Vajskebr, Dr. Max's CEO.

 

"By this acquisition Penta significantly contributes to strategically improve pharmaceutical distribution in Central Europe", said Dr. Stephan Goetz, Managing Partner of Fortlane Partners.

More transactionsYou might also be interested in...

February 2025
Icon: flag-DEIcon: flag-DE

Fortlane Partners advised

Exyte on the

Acquisition

of TTP Group

Value not disclosed

August 2022
Icon: flag-DEIcon: flag-DE

goetzpartners advised

Evotec SE on its

Acquisition

of Central Glass Germany GmbH

Value not disclosed

May 2022
Icon: flag-ITIcon: flag-DE

goetzpartners advised

EvoTec SE on the

Acquisition

of Rigenerand Srl

230,000,00 €

March 2022
Icon: flag-CHIcon: flag-DE

goetzpartners advised

Otto Group on the

Acquisition

of Medgate Holding & Better Doc

Value not disclosed

January 2022
Icon: flag-GBIcon: flag-CN

goetzpartners advised

Pharmaron on its

Acquisition

of Aesica Pharmaceuticals from Recipharm

Value not disclosed

June 2021
Icon: flag-DEIcon: flag-DE

goetzpartners advised

doctari group on the

Acquisition

of Planerio GmbH

Value not disclosed

March 2021
Icon: flag-GBIcon: flag-CN

goetzpartners advised

Pharmaron on its

Acquisition

of Allergan Biologics from AbbVie

Value not disclosed

October 2016
Icon: flag-ATIcon: flag-GB

goetzpartners advised

EUSA Pharma on the

Acquisition

of the global commercialization rights to the oncology product ISQETTE

Value not disclosed

December 2012
Icon: flag-CZIcon: flag-CZ

goetzpartners advised

Penta Investment on the

Acquisition

of Gehe Pharma

Value not disclosed

December 2010
Icon: flag-SEIcon: flag-SE

goetzpartners advised

KKR and Triton on the

Acquisition

of Ambea

Value not disclosed

October 2010
Icon: flag-DEIcon: flag-DE

goetzpartners advised

Chequers Capital on the

Acquisition

of Silver Care Holding

Value not disclosed

June 2008
Icon: flag-DEIcon: flag-DE

goetzpartners advised

TÜV Süd on the

Acquisition

of MSOURCE from its founder, Dr. Adriaan Hart de Ruijter

Value not disclosed

December 2004
Icon: flag-GBIcon: flag-GB

goetzpartners advised

a financial investor on the

Acquisition

of the Four Seasons Health Care Group

Value not disclosed